The New York City-based IPA Capital Markets team generated significant interest from lenders in providing acquisition ...
Shares of Biohaven Ltd. (BHVN) climbed 13% premarket on Monday after the biotech company said its treatment for a rare neurological disorder slowed the progress of the condition in a clinical trial.
While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...
You probably hear about the Dow Jones Industrial Average every day. But there may be a lot about its history and make-up that ...
In Depth
Mayo Clinic on MSN1 小时In Depth
COVID-19 vaccines for kids: What you need to know
Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.
The U.S. Food and Drug Administration said households are allowed to order 4 free tests. It says the new tests will detect ...
Troriluzole is part of Biohaven's non-migraine drugs spun off into a new company in 2022, after Pfizer acquired the migraine ...
Ideaya Biosciences has reported positive interim Phase 2 clinical trial data for darovasertib in neoadjuvant uveal melanoma, or UM, as well as a successful Type C meeting with the Food and Drug ...
“COVID is still out there, and it’s still causing severe disease, and it’s still causing death at a much higher rate than the ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
State Surgeon General Joseph Ladapo spread anti-vaccine misinformation by telling Floridians to avoid mRNA vaccines. Vaccine ...
Since cutting the ribbon on its inaugural commercial-scale Smart Factory in Bridgewater earlier this year, the San ...